Stay updated with breaking news from Replimune Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Caption Management LLC purchased a new stake in Replimune Group, Inc. (NASDAQ:REPL – Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 32,968 shares of the company’s stock, valued at approximately $766,000. Caption Management LLC owned approximately 0.06% […]
Key Insights Using the 2 Stage Free Cash Flow to Equity, Replimune Group fair value estimate is US$9.64 Replimune Group...
-- Health care stocks were slipping late Tuesday afternoon with the NYSE Health Care Index down 0.4% and the Health Care Select Sector SPDR Fund off 0.1%. The iShares Biotechnology ETF dropped...
Mirae Asset Global Investments Co. Ltd. boosted its stake in Replimune Group, Inc. (NASDAQ:REPL – Free Report) by 6.0% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 29,226 shares of the company’s stock after purchasing an additional 1,649 shares […]
Replimune Group said on Tuesday its experimental combination therapy to treat a common form of skin cancer failed to significantly remove or reduce cancerous lesions in a midstage study.